Skip to main content

Examining Correlates of Pre-ART and Early ART Adherence to Identify Key Factors Influencing Adherence Readiness

AIDS and Behavior volume 25, pages 113–123 (2021)Cite this article

Abstract

Although current standard of care for HIV typically involves immediate initiation of antiretroviral therapy (ART), most patients can benefit from first assessing adherence readiness and addressing any barriers to optimal adherence. A sample of 176 HIV patients planning to start ART enrolled in a controlled trial of an adherence intervention that was based on the Information Motivation and Behavioral skills (IMB) model of health behavior. We examined correlates of multiple adherence readiness measures, as well as electronically measured early ART adherence, to identify variables most important for readiness to adhere well at the start of treatment. Education level, recency of HIV diagnosis and knowledge and commitment to adherence were found to be associated with both ART readiness and early ART adherence. These findings suggest that resources to support adherence readiness should target more experienced HIV patients, and strive to bolster knowledge and attitudes that reinforce commitment to adherence.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Samji H, Taha TE, Moore D et al (2015) Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada. HIV Med 16(2):76–87

    CAS  PubMed  Google Scholar 

  2. Johnson MO, Dilworth SE, Stephens E, Lum PJ, Neilands TB. Expectancy and readiness-based predictors of treatment uptake among the urban poor living with HIV. J Acquir Immune Defic Syndr. 2011;58(5):469–71.

    PubMed  PubMed Central  Google Scholar 

  3. National Institute of Allergy and Infectious Diseases. Disease & Conditions. Available at: www.niaid.nih.gov/diseases-conditions/treatment-prevention. Accessed February 11, 2020

  4. Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. DICP. 2011;45(3):372–9.

    CAS  Google Scholar 

  5. Shuter J, Sarlo JA, Stubbs RO, Rode RA, Zingman BS (2012) Sequential antiretroviral adherence measurement using electronic bottle cap monitors in a cohort of HIV-infected adults. J Int Assoc Phys AIDS Care 11(2):94–97

    Google Scholar 

  6. Ortego C, Huedo-Medina TB, Llorca J, Sevilla L et al (2011) Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav 15(7):1381–1396

    PubMed  Google Scholar 

  7. Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ (2011) The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 52(6):793–800

    PubMed  PubMed Central  Google Scholar 

  8. Wagner GJ, Linnemayr S, Ghosh-Dastidar B, Currier JS, Hoffman R, Schneider S (2016) Supporting Treatment Adherence Readiness through Training (START) for patients with HIV on antiretroviral therapy: study protocol for a randomized controlled trial. Trials 17(1):162

    PubMed  PubMed Central  Google Scholar 

  9. Fernández MI, Hosek S, Warren JC, Jacobs RJ, Hernandez N, Martinez J (2011) Adolescent Medicine Trials Network. Development of an easy to use tool to assess HIV treatment readiness in adolescent clinical care settings. AIDS Care 23(11):1492–1499

    PubMed  PubMed Central  Google Scholar 

  10. Pasternak AO, De Bruin M, Bakker M, Berkhout B, Prins JM (2015) High current CD4+ T cell count predicts suboptimal adherence to antiretroviral therapy. PLoS ONE. https://doi.org/10.1371/journal.pone.0140791

    Article  PubMed  PubMed Central  Google Scholar 

  11. Bouton ME (2000) A learning theory perspective on lapse, relapse, and the maintenance of behavior change. Health Psychol 19(1S):57

    CAS  PubMed  Google Scholar 

  12. Thompson MA, Aberg JA, Hoy JF et al (2012) Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 308(4):387–402

    CAS  PubMed  Google Scholar 

  13. Gunthard HF, Aberg JA, Eron JJ et al (2014) Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA panel. JAMA 312(4):410–425

    PubMed  Google Scholar 

  14. World Health Organization (2016) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, 2nd edn. Recommendations for a public health approach, WHO, Geneva

    Google Scholar 

  15. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. Department of Health and Human Services. Available at https://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed February 11, 2020

  16. World Health Organization (2017) Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017. World Health Organization, Geneva

    Google Scholar 

  17. Maughan-Brown B, Smith P, Kuo C et al (2018) Readiness for antiretroviral therapy: implications for linking HIV-infected individuals to care and treatment. AIDS Behav 22(3):691–700

    PubMed  PubMed Central  Google Scholar 

  18. Balfour L, Tasca GA, Kowal J et al (2007) Development and validation of the HIV Medication Readiness Scale. Assessment 14(4):408–416

    PubMed  Google Scholar 

  19. Willey C, Redding C, Stafford J et al (2000) Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther 22(7):858–871

    CAS  PubMed  Google Scholar 

  20. Wagner G (2003) Placebo practice trials: the best predictor of adherence readiness for HAART among drug users? HIV Clin Trials 4(4):269–281

    PubMed  Google Scholar 

  21. Gross R, Bilker WB, Friedman HM, Coyne JC, Strom BL (2002) Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS 16(13):1835–1837

    PubMed  Google Scholar 

  22. Miller LG, Liu H, Hays RD et al (2002) How well do clinicians estimate patients’ adherence to combination antiretroviral therapy? J Gen Intern Med 17(1):1–11

    PubMed  PubMed Central  Google Scholar 

  23. Fisher JD, Fisher WA, Misovich SJ, Kimble DL, Malloy TE (1996) Changing AIDS risk behavior: effects of an intervention emphasizing AIDS risk reduction information, motivation, and behavioral skills in a college student population. Health Psychol 15(2):114

    CAS  PubMed  Google Scholar 

  24. Fisher JD, Fisher WA, Amico KR, Harman JJ (2006) An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol 25(4):462–473

    PubMed  Google Scholar 

  25. Amico KR, Harman JJ, Johnson BT (2006) Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr 41:285–297

    PubMed  Google Scholar 

  26. Amico KR, Orrell C (2013) Antiretroviral therapy adherence support: recommendations and future directions. J Int Assoc Phys AIDS Care 12(2):128–137

    Google Scholar 

  27. Starace F, Massa A, Amico KR, Fisher JD (2006) Adherence to antiretroviral therapy: an empirical test of the information-motivation-behavioral skills model. Health Psychol 25:153–162

    PubMed  Google Scholar 

  28. Azhar GS, Schneider S, Hoffman R, Gordon K, Ramirez D, Wagner GJ (2019) Evaluating measures of pre-ART adherence readiness through associations with ART adherence in the early months of treatment. AIDS Behav 24:1–7

    Google Scholar 

  29. Enriquez M, Cheng AL, McKinsey DS, Stanford J (2009) Development and efficacy of an intervention to enhance readiness for adherence among adults who had previously failed HIV treatment. AIDS Patient Care STDs 23(3):177–184

    PubMed  Google Scholar 

  30. Morgenstern T, Grimes D, Grimes R (2002) Assessment of readiness to initiate antiretroviral therapy. HIV Clin Trials 3(2):168–172

    PubMed  Google Scholar 

  31. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L et al (2000) Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 14(4):357–366

    CAS  PubMed  Google Scholar 

  32. Parienti JJ, Ragland K, Lucht F et al (2010) Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication. Clin Infect Dis 50:1192–1197

    PubMed  PubMed Central  Google Scholar 

  33. Kobin AB, Sheth NU (2011) Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother 45:372–379

    CAS  PubMed  Google Scholar 

  34. Pasternak AO, de Bruin M, Jurriaans S et al (2012) Modest nonadherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma. J Infect Dis 206:1443–1452

    CAS  PubMed  Google Scholar 

  35. Kennedy S, Goggin K, Nollen N (2004) Adherence to HIV medications: utility of the theory of self-determination. Cognit Ther Res 28(5):611–628

    Google Scholar 

  36. Stall R, Hoff C, Coates TJ et al (1996) Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: implications for secondary prevention efforts. J Acquir Immune Defic Syndr 11(2):151–160

    CAS  Google Scholar 

  37. Bruce J, Bruce A, Lynch S et al (2016) A pilot study to improve adherence among MS patients who discontinue treatment against medical advice. J Behav Med 39:276–287

    PubMed  Google Scholar 

  38. D’Zurilla T, Nezu A, Maydeu-Olivares A (2002) Social Problem-Solving Inventory-Revised (SPSI-R): manual. Multi-Health Systems, North Tonawanda

    Google Scholar 

  39. Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606–613

    CAS  PubMed  PubMed Central  Google Scholar 

  40. American Psychiatric Association (1994) Diagnostic statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington

    Google Scholar 

  41. Babor TF, Higgins-Biddle JC (2000) Alcohol screening and brief intervention: dissemination strategies for medical practice and public health. Addiction 95(5):677–686

    CAS  PubMed  Google Scholar 

  42. Henrich TJ, Hatano H, Bacon O et al (2017) HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: an observational study. PLoS Med 14(11):e1002417

    PubMed  PubMed Central  Google Scholar 

  43. Simoni JM, Amico KR, Smith L, Nelson K (2010) Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV/AIDS Rep 7(1):44–51

    PubMed  PubMed Central  Google Scholar 

  44. Palacio A, Garay D, Langer B, Taylor J, Wood BA, Tamariz L (2016) Motivational interviewing improves medication adherence: a systematic review and meta-analysis. J Gen Intern Med 31(8):929–940

    PubMed  PubMed Central  Google Scholar 

  45. Burch LS, Smith CJ, Phillips AN, Johnson MA, Lampe FC (2016) Socioeconomic status and response to antiretroviral therapy in high-income countries: a literature review. AIDS 30(8):1147–1162

    CAS  PubMed  Google Scholar 

  46. Kerkerian G, Kestler M, Carter A et al (2018) Attrition across the HIV cascade of care among a diverse cohort of women living with HIV in Canada. J Acquir Immune Defic Syndr 79(2):226–236

    PubMed  Google Scholar 

  47. Enderis BO, Hebo SH, Debir MK, Sidamo NB, Shimber MS (2019) Predictors of time to first line antiretroviral treatment failure among adult patients living with HIV in public health facilities of Arba Minch Town. Southern Ethiopia Ethiop J Health Sci 29(2):175–186

    PubMed  Google Scholar 

  48. Claborn KR, Meier E, Miller MB, Leffingwell TR (2015) A systematic review of treatment fatigue among HIV-infected patients prescribed antiretroviral therapy. Psychol Health Med 20(3):255–265

    PubMed  Google Scholar 

  49. Kim MH, Zhou A, Mazenga A et al (2016) Why did i stop? Barriers and facilitators to uptake and adherence to ART in ooption B+ HIV care in Lilongwe, Malawi. PLoS ONE 11(2):e0149527

    PubMed  PubMed Central  Google Scholar 

  50. Lambert RF, Orrell C, Bangsberg DR, Haberer JE (2018) Factors that motivated otherwise healthy HIV-positive young adults to access HIV testing and treatment in South Africa. AIDS Behav 22(3):733–741

    PubMed  Google Scholar 

  51. Katz IT, Dietrich J, Tshabalala G et al (2015) Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study. AIDS Behav 19(4):704–714

    PubMed  PubMed Central  Google Scholar 

  52. Musheke M, Bond V, Merten S (2013) Deterrents to HIV-patient initiation of antiretroviral therapy in urban Lusaka, Zambia: a qualitative study. AIDS Patient Care STDS 27(4):231–241

    PubMed  Google Scholar 

  53. Uthman OA, Magidson JF, Safren SA, Nachega JB (2014) Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep 11(3):291–307

    PubMed  PubMed Central  Google Scholar 

  54. Gonzalez A, Barinas J, O’Cleirigh C (2011) Substance use: impact on adherence and HIV medication treatment. Curr HIV/AIDS Rep 8:223–234

    PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Medicine, UCLA, Los Angeles, CA, USA

    Kyle Gordon & Risa M. Hoffman

  2. Long Beach Education and Research Consultants, Long Beach, CA, USA

    Gulrez Azhar & Glenn J. Wagner

  3. Social and Economic Wellbeing Division, RAND Corporation, 1776 Main St., Santa Monica, CA, 90401, USA

    Daniel Ramirez & Stefan Schneider

Authors
  1. Kyle Gordon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Risa M. Hoffman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gulrez Azhar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel Ramirez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stefan Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Glenn J. Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Glenn J. Wagner.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gordon, K., Hoffman, R.M., Azhar, G. et al. Examining Correlates of Pre-ART and Early ART Adherence to Identify Key Factors Influencing Adherence Readiness. AIDS Behav 25, 113–123 (2021). https://doi.org/10.1007/s10461-020-02947-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-020-02947-6

Keywords

  • HIV
  • Adherence
  • ART
  • Readiness